Home > Analytics > BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Intrinsic Value | Fundamental Analysis

BOM : 524663     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Jul 06,2022
Price(EOD): ₹ 26.75
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 115.56 Cr
Value of ₹ 1 Lac invested in BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
on Jul 06,2017 (price: ₹ 29.25)

₹ 1 L

₹ 0.91 L

1W : -4.5% 1M : -4.5% 1Y : -60.3%
COMMUNITY POLL
for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Please provide your vote to see the results
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION -4.5% -4.5% -60.3%
SUN PHARMACEUTICAL INDUSTRIES -0.3% -3% 21%
DIVIS LABORATORIES 0.7% 3.1% -16.5%
DR REDDYS LABORATORIES 0.6% 1.9% -19.6%
CIPLA -0.8% -3.9% -4.9%
GLAND PHARMA -4.6% -11.1% -23%
PIRAMAL ENTERPRISES 2% -5.5% -29.9%
CADILA HEALTHCARE 1.5% -0.9% -43.6%
TORRENT PHARMACEUTICALS 1.8% 4.2% -0.7%

FUNDAMENTAL ANALYSIS OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

 
Fundamentals Score
[ Q(TTM): Dec2021, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

 
Valuation Score
[As on : Jul 06,2022 ]

Ratio Standalone
P/E
P/B
P/S
-
P/E Calculated based on EPS of -4.19
[ Mar2021 - Standalone Results ]

3.39
P/B Calculated based on Book Value of 7.88
[ Mar2021 - Standalone Results ]

1.42
P/S Calculated based on Revenues of 81.546 Cr
[ TTM - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 22% undervalued companies ! Discover More →

FAIR VALUE OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
99%
-9%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION



BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.8
0.15
1.05
0.67
-
-
-
-
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

Pledged Promoter Shares
0 %
As on : Mar2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-29.44%
129.05%
90.33%
96.46%
-31.26%
122.54%
92.1%
91.44%
QtrlyTrend
4
Latest Qtr: Dec2021
Quarterly Result Analysis →

Insights 💡 BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is one of the top 41% companies with good quarterly result uptrend ! Discover More →

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION


Is BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION good for long term investment?

As on Jul 06,2022, the Fundamentals of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION look Poor and hence it may not be good for long term investment ! See Financial Performance of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION UnderValued or OverValued?

As on Jul 06,2022, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?

As on Jul 06,2022, the Intrinsic Value of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is Rs. 21.38 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -11.36
Fair Value [Median EV / Sales Model] : Rs. 13.46
Fair Value [Median Price / Sales Model] : Rs. 29.30
Median Fair Value of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION : Rs. 21.38

Is BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION trading at a Premium or Discount?

As on Jul 06,2022, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is trading at a Premium of 25% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].